Britan’s Research on AstraZeneca: After European countries temporarily suspended the use of the AstraZeneca vaccine, Britain has admitted to “plausible” risks arising from the vaccine. Its trusted Medicines and Healthcare products Regulatory Authority (MHRA) found there had been 79 cases of blood clots in the UK following vaccination, among whom 19 died. This was among a total of 20 million who had been given the vaccine. That suggests that four in a million could develop a clot, and one in a million could die of it. A minuscule risk, but a risk nevertheless, that affects younger people more. If India is approaching a couple of million vaccinations a day, that could mean a death a day from taking this vaccine. But there is further study underway into the “evolving evidence” over the rare side effects of this vaccine, says MHRA CEO Dr June Reine. UK Health Secretary Matt Hancock says the risk is no more than the risk of developing a blood clot during a long-haul flight.